Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Principal Investigator: Maureen Jonas, MD
Department: Gastroenterology, Center for Childhood Liver Disease
Protocol Status: Open for Recruitment
Trial Description: This is research into other ways to detect cirrhosis, or the degree of liver fibrosis. The study uses a combination of special research blood tests and a technology called “transient elastography” to assess the severity of liver scarring. The elastography is done with a machine called a “FibroScan” (Echosens, Paris, France), that uses ultrasound technology to measure the stiffness of the liver.
The objective of this study is to determine if liver stiffness as measured by elastography correlates to the amount of scarring (fibrosis) seen on the liver biopsy. If it does, in the future some liver biopsies may be avoided.
Protocol Status: Open for recruitment
Recruitment Info: The patient must have had a liver biopsy within 1 year of the study. In addition, subjects may not be pregnant, have ascites (fluid in the abdomen) or a BMI greater than 35.
PI contact: Maureen Jonas, MD, Center for Childhood Liver Disease
PI Phone: 617-355-5837
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”